Generally, subcutaneous injections are significantly less painful than intramuscular ones
Singh AK, Mishra G, Maurya A, Awasthi R, Kumari K, Thakur A, Rai A, Rai GK, Sharma B, Kulkarni GT, Singh SK (2019) Role of TREM2 in Alzheimers disease and its consequences on - amyloid, tau and neurofibrillary tangles
68 (Supplement 1)
Many people notice reduced appetite within a few weeks, with visible weight loss typically appearing after 48 weeks
There's no doubt that Roche is playing catchup in the category, one of a lengthening list of pharma companies that are hoping to hit on effective 'me-too' products that can make a dent in the substantial lead held by market leaders Novo Nordisk and Eli Lilly, which already have injectable GLP-1s for diabetes and obesity on the market